| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 76 | ₹29,716 |
| Retail (Max — 13 Lots) | 13 | 494 | ₹193,154 |
| S-HNI (Min — 14 Lots) | 14 | 532 | ₹208,012 |
| B-HNI (Min — 68 Lots) | 68 | 2,584 | ₹1,010,344 |
Senores Pharmaceuticals Ltd. is proposing an IPO on NSE & BSE under the Mainboard category.
Opens 20 Dec 2024, closes 24 Dec 2024. Listing: 01 Jan 2025. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Senores Pharmaceuticals Ltd. IPO is subscribed 1.00 times by Dec 24, 2024. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Senores Pharmaceuticals Ltd. IPO retail category is subscribed 1.00 times as of 24 Dec 2024. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 20 Dec 2024 and closes 24 Dec 2024. Min investment: ₹14,858 (1 lot = 38 shares). UPI mandate: 5:00 PM on 24 Dec 2024.
The Senores Pharmaceuticals Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 30 Dec 2024. Refunds: on 31 Dec 2024.
The Senores Pharmaceuticals Ltd. IPO listing date is 01 Jan 2025, Wednesday. Listed on: NSE & BSE. Issue price: ₹391. Estimated listing: ₹391. GMP: NIL.
The Senores Pharmaceuticals Ltd. IPO closes on 24 Dec 2024, Tuesday. UPI mandate: 5:00 PM on 24 Dec 2024. Allotment: 30 Dec 2024. Listing: 01 Jan 2025.